Form 8-K - Current report:
SEC Accession No. 0001829126-25-005224
Filing Date
2025-07-21
Accepted
2025-07-21 13:55:10
Documents
14
Period of Report
2025-07-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nexalintec_8k.htm   iXBRL 8-K 32201
2 EXHIBIT 10.1 nexalintec_ex10-1.htm EX-10.1 62412
  Complete submission text file 0001829126-25-005224.txt   318620

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE nxl-20250717.xsd EX-101.SCH 3750
4 XBRL DEFINITION FILE nxl-20250717_def.xml EX-101.DEF 26614
5 XBRL LABEL FILE nxl-20250717_lab.xml EX-101.LAB 36724
6 XBRL PRESENTATION FILE nxl-20250717_pre.xml EX-101.PRE 25238
16 EXTRACTED XBRL INSTANCE DOCUMENT nexalintec_8k_htm.xml XML 5832
Mailing Address 1776 YORKTOWN SUITE 550 HOUSTON TX 77056
Business Address 1776 YORKTOWN SUITE 550 HOUSTON TX 77056 (832) 260-0222
Nexalin Technology, Inc. (Filer) CIK: 0001527352 (see all company filings)

EIN.: 275566468 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41507 | Film No.: 251136775
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)